|
Community Surveillance of Congestive Heart Failure Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Community Surveillance of Congestive Heart Failure conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Community Surveillance of Congestive Heart Failure Clinical research trials and Community Surveillance of Congestive Heart Failure healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Community Surveillance of Congestive Heart Failure. Community Surveillance of Congestive Heart Failure Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Community Surveillance of Congestive Heart Failure clinical trial. Subjects frequently obtain the most expert healthcare possible for their Community Surveillance of Congestive Heart Failure condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Community Surveillance of Congestive Heart Failure  Community Surveillance of Congestive Heart Failure
Community Surveillance of Congestive Heart Failure
For Condition: Heart Diseases,Heart Failure, Congestive,Cardiovascular Diseases,Heart Failure
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To conduct a surveillance study of congestive heart failure (CHF).
Details: DESIGN NARRATIVE: Systematic surveillance was conducted of CHF among residents, 35-84 years old, of the Minneapolis-St.Paul metropolitan area (population 2.45 million, 1995 estimate) in two complementary domains: 1) hospitalization for CHF in two calendar years, five years apart (1995 and the year 2000); and 2) newly diagnosed CHF over a 9-year period (1993-2001) among members of a large Health Maintenance Organization (HMO). The magnitude and characteristics of hospitalized CHF were assessed in all 21 acute care hospitals of the metropolitan area. One-third of all discharges with ICD-9 CHF codes were sampled randomly (n about 5,000 per surveillance year), abstracted by trained nurses, and classified according to clinical criteria and the results of diagnostic tests. Newly diagnosed CHF was distinguished from recurrent episodes of decompensated CHF by thorough review of the hospital record. A complementary perspective on CHF, including the outpatient setting, was provided by a systematic study of members of HealthPartners, one of the largest HMOs in Minneapolis-St. Paul. Using the HealthPartners database, all newly diagnosed CHF cases between January 1, 1993 and December 31, 2001 (n about 1,900) were identified and the diagnosis validated. Beginning in January 1, 1999, newly diagnosed CHF cases were identified on an ongoing basis (n about 600), surveyed by mail, and followed for one-year from the original diagnosis. Surveillance of the HealthPartners population supplemented hospital surveillance and contributed data on incidence, prevalence, treatment, use of resources, and patient outcomes.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: 35 Years/84 Years
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
EyalShahar, , University of Minnesota, Twin Cities
Additional Information:
Study ID Numbers: 5036;
Study Start Date: August 1998
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005517
Other Heart Diseases Studies:
1. Beta-Blocker Evaluation in Survival Trial (BEST)
2. Genetic Architecture of Heart Disease in Rural Brazil
3. Reversal of Ventricular Remodeling with Toprol-XL
4. Congestive Heart Failure Trends in the Elderly 1970-94
5. Efficacy and Cost Effectiveness of Relaxation and Response to CHF
Related Studies:
Other Heart Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Community Surveillance of Congestive Heart Failure
|
|
|
|
|
|
|
|
